Dose-dependent effects of IL-17 on IL-13-induced airway inflammatory responses and airway hyperresponsiveness

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 3859-3868

  Kinyanjui, Margaret W ^a   Shan, Jichuan ^a   Nakada, Emily M ^a   Qureshi, Salman T ^a   Fixman, Elizabeth D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 17;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; GAMMA DELTA T LYMPHOCYTE; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CD4-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84875969208     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200506     Document Type: Article

References (57)

1. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
2. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8: 885-889.
3. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. [see comments] Science 282: 2258-2261.
4. Yang, M., S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2001. Interleukin-13 mediates airways hy-perreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 25: 522-530.
5. Hoeck, J., and M. Woisetschläger. 2001. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J. Immunol. 167: 3216-3222.
6. Matsukura, S., C. Stellato, S. N. Georas, V. Casolaro, J. R. Plitt, K. Miura, S. Kurosawa, U. Schindler, and R. P. Schleimer. 2001. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 24: 755-761.
7. + myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J. Immunol. 182: 623-635.
8. Neilsen, C. V., and P. J. Bryce. 2010. Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin. Exp. Allergy 40: 427-434.
9. Chakir, J., J. Shannon, S. Molet, M. Fukakusa, J. Elias, M. Laviolette, L. P. Boulet, and Q. Hamid. 2003. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-b, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111: 1293-1298.
10. Doe, C., M. Bafadhel, S. Siddiqui, D. Desai, V. Mistry, P. Rugman, M. McCormick, J. Woods, R. May, M. A. Sleeman, et al. 2010. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138: 1140-1147.
11. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Pagé, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438.
12. Agache, I., C. Ciobanu, C. Agache, and M. Anghel. 2010. Increased serum IL-17 is an independent risk factor for severe asthma. Respir. Med. 104: 1131-1137.
13. H17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123: 1185-1187.
14. Bullens, D. M., E. Truyen, L. Coteur, E. Dilissen, P. W. Hellings, L. J. Dupont, and J. L. Ceuppens. 2006. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7: 135.
15. Zhao, Y., J. Yang, Y. D. Gao, and W. Guo. 2010. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 151: 297-307.
16. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95: 843-852.
17. Shannon, J., P. Ernst, Y. Yamauchi, R. Olivenstein, C. Lemiere, S. Foley, L. Cicora, M. Ludwig, Q. Hamid, and J. G. Martin. 2008. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 133: 420-426.
18. Hellings, P. W., A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens. 2003. Interleukin-17 orchestrates the gran-ulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28: 42-50.
19. Liang, S. C., A. J. Long, F. Bennett, M. J. Whitters, R. Karim, M. Collins, S. J. Goldman, K. Dunussi-Joannopoulos, C. M. Williams, J. F. Wright, and L. A. Fouser. 2007. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179: 7791-7799.
20. Liu, Y., J. Mei, L. Gonzales, G. Yang, N. Dai, P. Wang, P. Zhang, M. Favara, K. C. Malcolm, S. Guttentag, and G. S. Worthen. 2011. IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J. Immunol. 186: 3197-3205.
21. Zrioual, S., R. Ecochard, A. Tournadre, V. Lenief, M. A. Cazalis, and P. Miossec. 2009. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J. Immunol. 182: 3112-3120.
22. H17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181: 4089-4097.
23. Wakashin, H., K. Hirose, Y. Maezawa, S. Kagami, A. Suto, N. Watanabe, Y. Saito, M. Hatano, T. Tokuhisa, Y. Iwakura, et al. 2008. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178: 1023-1032.
24. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957.
25. He, R., H. Y. Kim, J. Yoon, M. K. Oyoshi, A. MacGinnitie, S. Goya, E. J. Freyschmidt, P. Bryce, A. N. McKenzie, D. T. Umetsu, et al. 2009. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J. Allergy Clin. Immunol. 124: 761-770.e1.
26. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
27. Song, C., L. Luo, Z. Lei, B. Li, Z. Liang, G. Liu, D. Li, G. Zhang, B. Huang, and Z. H. Feng. 2008. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 181: 6117-6124.
28. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensiti-zation is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
29. Murdoch, J. R., and C. M. Lloyd. 2010. Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing gammadeltaT cells. Am. J. Respir. Crit. Care Med. 182: 464-476.
30. Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203: 2715-2725.
31. + dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol. 5: 53-65.
32. McCusker, C. T., Y. Wang, J. Shan, M. W. Kinyanjui, A. Villeneuve, H. Michael, and E. D. Fixman. 2007. Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J. Immunol. 179: 2556-2564.
33. T) method. Methods 25: 402-408.
34. Pope, S. M., P. C. Fulkerson, C. Blanchard, H. S. Akei, N. M. Nikolaidis, N. Zimmermann, J. D. Molkentin, and M. E. Rothenberg. 2005. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280: 13952-13961.
35. Therien, A. G., V. Bernier, S. Weicker, P. Tawa, J. P. Falgueyret, M. C. Mathieu, J. Honsberger, V. Pomerleau, A. Robichaud, R. Stocco, et al. 2008. Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. Am. J. Respir. Cell Mol. Biol. 39: 26-35.
36. Zhen, G., S. W. Park, L. T. Nguyenvu, M. W. Rodriguez, R. Barbeau, A. C. Paquet, and D. J. Erle. 2007. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am. J. Respir. Cell Mol. Biol. 36: 244-253.
37. Hoeck, J., and M. Woisetschläger. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-a-induced fibroblasts. J. Immunol. 166: 4507-4515.
38. Liddiard, K., J. S. Welch, J. Lozach, S. Heinz, C. K. Glass, and D. R. Greaves. 2006. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol. Biol. 7: 45.
39. Wirnsberger, G., D. Hebenstreit, G. Posselt, J. Horejs-Hoeck, and A. Duschl. 2006. IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites. Eur. J. Immunol. 36: 1882-1891.
40. Nabe, T., F. Hosokawa, K. Matsuya, T. Morishita, A. Ikedo, M. Fujii, N. Mizutani, S. Yoshino, and D. D. Chaplin. 2011. Important role of neutrophils in the late asthmatic response in mice. Life Sci. 88: 1127-1135.
41. Sun, D., M. Novotny, K. Bulek, C. Liu, X. Li, and T. Hamilton. 2011. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12: 853-860.
42. Sergejeva, S., S. Ivanov, J. Lötvall, and A. Lindén. 2005. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33: 248-253.
43. Chen, Y., P. Thai, Y. H. Zhao, Y. S. Ho, M. M. DeSouza, and R. Wu. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278: 17036-17043.
44. H17 cells in asthma and COPD. Annu. Rev. Physiol. 72: 495-516.
45. Chen, Z., and J. J. O'Shea. 2008. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 41: 87-102.
46. Ghoreschi, K., A. Laurence, X. P. Yang, K. Hirahara, and J. J. O'Shea. 2011. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 32: 395-401.
47. Finkelman, F. D., S. P. Hogan, G. K. K. Hershey, M. E. Rothenberg, and M. Wills-Karp. 2010. Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 184: 1663-1674.
48. H2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 207: 2479-2491.
49. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
50. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coex-pressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
51. Aarvak, T., M. Chabaud, P. Miossec, and J. B. Natvig. 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162: 1246-1251.
52. Fei, M., S. Bhatia, T. B. Oriss, M. Yarlagadda, A. Khare, S. Akira, S. Saijo, Y. Iwakura, B. A. Fallert Junecko, T. A. Reinhart, et al. 2011. TNF-α from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neu-trophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. USA 108: 5360-5365.
53. Wilson, R. H., G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook. 2009. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180: 720-730.
54. Lalor, S. J., L. S. Dungan, C. E. Sutton, S. A. Basdeo, J. M. Fletcher, and K. H. Mills. 2011. Caspase-1-processed cytokines IL-1β and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 186: 5738-5748.
55. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
56. Guo, L., G. Wei, J. Zhu, W. Liao, W. J. Leonard, K. Zhao, and W. Paul. 2009. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 106: 13463-13468.
57. Fulkerson, P. C., C. A. Fischetti, L. M. Hassman, N. M. Nikolaidis, and M. E. Rothenberg. 2006. Persistent effects induced by IL-13 in the lung. Am. J. Respir. Cell Mol. Biol. 35: 337-346.